Results 211 to 220 of about 75,057 (290)

Discovery of Sphingosine-1-Phosphate Receptor Modulators as Potential CHI3L1 Inhibitors by Ligand-Based Virtual Screening and Molecular Dynamics Simulations. [PDF]

ACS Omega
Aledavood E, Gil C, Comabella M, Martinez A.   +3 more
europepmc   +1 more source

PET Imaging of Sphingosine-1-Phosphate Receptor 1 with [¹⁸F]TZ4877 in Nonhuman Primates. [PDF]

Mol Imaging Biol
Gu J, Zheng MQ, Holden D, Fowles K, Qiu L, Felchner Z, Zhang L, Ropchan J, Gropler RJ, Carson RE, Tu Z, Huang Y, Hillmer AT.   +12 more
europepmc   +1 more source

Deletion of sphingosine 1-phosphate receptor 1 in myeloid cells reduces hepatic inflammatory macrophages and attenuates MASH. [PDF]

Hepatol Commun
Parthasarathy G, Venkatesan N, Sidhu GS, Song MJ, Liao CY, Barrow F, Mauer A, Sehrawat T, Nakao Y, Daniel PV, Dasgupta D, Pavelko K, Revelo XS, Revelo XS, Malhi H.   +14 more
europepmc   +1 more source

Inhibition of Sphingosine-1-Phosphate Receptor 2 (S1P₂) Attenuates Imiquimod-Induced Psoriasis-Like Skin Inflammation in BALB/c Mice. [PDF]

Biomol Ther (Seoul)
Lee JH, Im DS.
europepmc   +1 more source

Efficacy and safety of sphingosine-1-phosphate receptor modulators in the management of inflammatory bowel disease: a systematic review and meta-analysis. [PDF]

Gastroenterol Hepatol Bed Bench
Darmadi D, Ariestine DA, Ahmad H, Sitepu YIF.   +3 more
europepmc   +1 more source

Pseudoirreversible inhibition elicits persistent efficacy of a sphingosine 1-phosphate receptor 1 antagonist. [PDF]

Nat Commun
Maruyama Y, Ohsawa Y, Suzuki T, Yamauchi Y, Ohno K, Inoue H, Yamamoto A, Hayashi M, Okuhara Y, Muramatsu W, Namiki K, Hagiwara N, Miyauchi M, Miyao T, Ishikawa T, Horie K, Hayama M, Akiyama N, Hirokawa T, Akiyama T.   +19 more
europepmc   +1 more source

Structural analysis of sphingosine 1-phosphate receptor

Proceedings for Annual Meeting of The Japanese Pharmacological Society, 2020
Shota Suzuki, Yoko Hiroaki, Atunori Oshima, Yoshinori Fujiyoshi   +3 more
openaire   +2 more sources

Zonation and ligand and dose dependence of sphingosine 1-phosphate receptor-1 signalling in blood and lymphatic vasculature. [PDF]

Cardiovasc Res
Del Gaudio I, Nitzsche A, Boyé K, Bonnin P, Poulet M, Nguyen TQ, Couty L, Ha HTT, Nguyen DT, Cazenave-Gassiot A, Ben Alaya K, Thérond P, Chun J, Wenk MR, Proia RL, Henrion D, Nguyen LN, Eichmann A, Camerer E.   +18 more
europepmc   +1 more source

Blocking the Sphingosine-1-Phosphate Receptor 2 (S1P₂) Reduces the Severity of Collagen-Induced Arthritis in DBA-1J Mice. [PDF]

Int J Mol Sci
Lee JH, Lee JE, Im DS.
europepmc   +1 more source

The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectives.

Pharmacology and Therapeutics, 2017
A. Huwiler, U. Zangemeister‐Wittke
semanticscholar   +1 more source